- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Sep 28, 2022 at 00:00:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Sep 28, 2022 | T-555-20 | CMC | Janssen Inc. Et Al. V. Apotex Inc. (Patent - Macitentan*) | Toronto | 1 h |
| Sep 28, 2022 | A-57-21 | APP | Maoz Betser-zilevitch V. Petrochina Canada Ltd (Patent) | Toronto | 5.5 h |
| Sep 29, 2022 | T-1488-20 | CMC | Steelhead Lng (aslng) Ltd Et Al. V. Seven Gens Energy Ltd, Rockies Lng Et Al (Patent) | Ottawa | 1 h |
| Sep 29, 2022 | T-1894-22 | CMC | Bell Media Inc. Et Al. V. John Doe 1 Et Al. (Copyright) | Ottawa | 1 h |
| Sep 29, 2022 | T-1257-22 | CMC | Bell Media Ind Et Al. V. Marshall Macciacchera Et Al (Copyright) | Ottawa | 1 h |
| Oct 4, 2022 | T-673-22 | M | Groupe Zoom Media Inc. V. Zoom Video Communications, Inc. (Trade Mark) | Toronto | 1 h |
| Oct 4, 2022 | T-788-21 | CMC | Boehringer Ingelheim (canada) Ltd. Et Al V. Jamp Pharma Corporation (Patent - Linagliptin*) | Toronto | 30 m |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Oct 17, 2022 | T-1790-17 | Valley Blades Ltd V. Usinage Pro-24 Inc. C/o/b As Nordik Blades (Patent) | Ottawa | 7 d |
| Oct 17, 2022 | T-416-19 | Usinage Pro-24 Inc. V. Valley Blades Ltd (Patent) | Ottawa | 7 d |
| Oct 17, 2022 | T-126-19 | Tekna Plasma Systems Inc. V. Ap&c Advanced Powders & Coatings Inc. (Patent) | Montréal | 15 d |
| Nov 9, 2022 | T-126-19 | Tekna Plasma Systems Inc. V. Ap&c Advanced Powders & Coatings Inc. (Patent) | Montréal | 2 d |
| Nov 14, 2022 | T-577-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-581-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-573-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-572-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-1686-18 | Wheel Monitor Inc. V. Cleral Inc. Et Al (Patent) | Toronto | 10 d |
| Nov 14, 2022 | T-561-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-560-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-559-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-557-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 21, 2022 | T-2060-19 | 9209-6601 Quã?bec Inc. C. Rep Solution Interactive Inc. (Trade Mark) | Montréal | 8 d |
| Dec 5, 2022 | T-1213-21 | Lundbeck Canada Inc. Et Al. V. Apotex Inc. Et Al. (Patent - Vortioxetine*) | Toronto | 10 d |
| Dec 5, 2022 | T-668-21 | Lundbeck Canada Inc. Et Al. V. Apotex Inc. Et Al. (Patent - Vortioxetine*) | Toronto | 10 d |
| Dec 19, 2022 | T-557-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-559-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-577-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-573-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-560-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-561-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-581-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-572-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 3 d |
| Jan 9, 2023 | T-1007-20 | Medexus Pharmaceuticals Inc. Et Al. V. Accord Healthcare Inc. Et Al (Patent) | Toronto | 14 d |
| Feb 13, 2023 | T-512-20 | 2660722 Ontario Inc. Et Al. V. Vanpak Limited Et Al. (unknown) | Ottawa | 10 d |
| Feb 20, 2023 | T-374-21 | Vidã?otron Ltã?e Et Al C. Technologies Konek Inc. Et Al (Copyright) | Montréal | 8 d |
| Feb 20, 2023 | T-343-20 | The Noco Company, Inc. V. Canadian Tire Corporation, Limited (Patent) | Toronto | 7 d |
| Feb 27, 2023 | T-788-21 | Boehringer Ingelheim (canada) Ltd. Et Al V. Jamp Pharma Corporation (Patent - Linagliptin*) | Toronto | 15 d |
| Mar 3, 2023 | T-343-20 | The Noco Company, Inc. V. Canadian Tire Corporation, Limited (Patent) | Toronto | 1 d |
| Mar 20, 2023 | T-703-20 | Kaira District Coop Milk Producers Union Ltd Et Al V Amul Canada Ltd Et Al (Trade Mark) | Toronto | 5 d |
| Apr 11, 2023 | T-711-20 | Bell Canada V. Skychoice Communications Inc. (Trade Mark) | Toronto | 8 d |
| Apr 17, 2023 | T-127-19 | Fromfroid S.a. C. 1048547 Ontario Inc. Et Al. (Patent) | Montréal | 5 d |
| Apr 17, 2023 | T-609-20 | Wanakome Inc. V. Eric Martin Et Al. (Trade Mark) | Montréal | 10 d |
| May 8, 2023 | T-1924-17 | Bell Canada Et Al V. Watchnsavenow Inc. Et Al (Copyright) | Toronto | 10 d |
| Jun 5, 2023 | T-1966-21 | Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*) | To be determined (TrialJA) | 8 d |
| Jun 5, 2023 | T-379-21 | Molo Design, Ltd. V. Chanel Canada Ulc Et Al. (Patent) | Montréal | 10 d |
| Jun 5, 2023 | T-1168-21 | Dr. Reddy's Laboratories Ltd. Et Al V. Janssen Inc, Et Al (Patent) | Toronto | 10 d |
| Jun 19, 2023 | T-607-21 | Apotex Inc. V. Janssen Inc. Et Al. (Patent - Abiraterone*) | Toronto | 10 d |
| Jun 19, 2023 | T-1966-21 | Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*) | To be determined (TrialJA) | 2 d |
| Jul 10, 2023 | T-1475-21 | Pharmacyclics Llc Et Al. V. Natco Pharma (canada) Inc. (Patent - Ibrutinib*) | Toronto | 15 d |
| Jul 10, 2023 | T-1472-21 | Pharmacyclics Llc Et Al. V. Natco Pharma (canada) Inc. (Patent - Ibrutinib*) | Toronto | 15 d |
| Sep 11, 2023 | T-1994-21 | Allergan, Inc. Et Al. V. Juno Pharmaceuticals Corp. (Patent - Bimatoprost*) | Toronto | 10 d |
| Sep 11, 2023 | T-1962-21 | Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*) | To be determined (TrialJA) | 5 d |
| Sep 21, 2023 | T-1962-21 | Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*) | To be determined (TrialJA) | 2 d |
| Sep 25, 2023 | T-1869-21 | Bayer Inc. Et Al. V. Sandoz Canada Inc. (Patent - Riociguat*) | Toronto | 2 d |
| Oct 3, 2023 | T-1869-21 | Bayer Inc. Et Al. V. Sandoz Canada Inc. (Patent - Riociguat*) | Toronto | 4 d |
| Oct 3, 2023 | T-15-22 | Boehringer Ingleheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent - Linagliptin*) | Toronto | 16 d |
| Oct 10, 2023 | T-1869-21 | Bayer Inc. Et Al. V. Sandoz Canada Inc. (Patent - Riociguat*) | Toronto | 4 d |
| Oct 16, 2023 | T-151-22 | Takeda Canada V. Apotex, Takeda Pharmaceutical Co & Takeda Pharma Usa (Patent - Dexlansoprazole*) | To be determined (TrialJA) | 10 d |
| Oct 16, 2023 | T-653-21 | Apotex Inc. V. Servier Canada Inc. (Patent - Perindopril*) | Toronto | 10 d |
| Oct 30, 2023 | T-192-22 | Novartis Pharmaceuticals Canada Inc. Et Al. V. Teva Canada Limited (Patent - Sacubitril*) | Ottawa | 10 d |
| Nov 9, 2023 | T-151-22 | Takeda Canada V. Apotex, Takeda Pharmaceutical Co & Takeda Pharma Usa (Patent - Dexlansoprazole*) | To be determined (TrialJA) | 2 d |
| Nov 20, 2023 | T-1386-21 | Jcai Inc. V. Wiseleap Solutions Inc. Et Al (Patent) | To be determined (TrialJA) | 12 d |
| Jan 15, 2024 | T-1006-22 | Gilead Sciences, Inc. Et Al V. Apotex Inc. (Trade Mark - Tenofovir*) | Toronto | 15 d |
| Jan 15, 2024 | T-1004-22 | Gilead Sciences, Inc. Et Al V. Apotex Inc. (Patent - Tenofovir*) | Toronto | 15 d |
| Jan 22, 2024 | T-971-22 | Lundbeck Canada Inc. Et Al. V. Sandoz Canada Inc. (Patent - Vortioxetine*) | Toronto | 10 d |
| Feb 5, 2024 | T-997-22 | Janssen Pharmaceutica N. V. V. Apotex Inc. (Patent - Rilpivirine*) | Toronto | 8 d |
| Mar 11, 2024 | T-1181-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 13 d |
| Mar 11, 2024 | T-1188-22 | Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 13 d |
| Mar 11, 2024 | T-1175-22 | Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent) | Toronto | 13 d |
| Mar 11, 2024 | T-1176-22 | Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 13 d |
| Mar 11, 2024 | T-1178-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 13 d |
| Mar 11, 2024 | T-1187-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 13 d |
| Apr 4, 2024 | T-1175-22 | Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent) | Toronto | 2 d |
| Apr 4, 2024 | T-1176-22 | Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 2 d |
| Apr 4, 2024 | T-1178-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 2 d |
| Apr 4, 2024 | T-1181-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 2 d |
| Apr 4, 2024 | T-1187-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 2 d |
| Apr 4, 2024 | T-1188-22 | Boehringer Ingelheim (canada) Ltd. Et Al V. Apotex Inc. (Patent - Linagliptin*) | Toronto | 2 d |
| May 6, 2024 | T-1563-22 | Boehringer Ingelheim(canada) Ltd Et Al V. Jamp Pharma Corp. (Patent - Nintedanib*) | Toronto | 10 d |
| May 27, 2024 | T-1563-22 | Boehringer Ingelheim(canada) Ltd Et Al V. Jamp Pharma Corp. (Patent - Nintedanib*) | Toronto | 2 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Oct 17, 2022 | T-1091-21 | Gianpiero Pugliese Et Al. V. Scott Mccuaig Et Al. | Copyright Infringement [Applications] | Toronto | 3 h |
| Oct 25, 2022 | T-690-22 | Clark Wilson Llp V. 7299362 Canada Inc. | Trade Mark Expungement | Toronto | 3 h |
| Oct 26, 2022 | T-734-22 | Made In Nature, Llc V. Pharmavite Llc | Trade Mark - Appeal of a decision of the Registrar | Toronto | 2 h |
| Oct 31, 2022 | T-1752-21 | The Coca-cola Company V. Agc | Patent - Appeal of a Decision of Commissioner | Toronto | 1 d |
| Nov 2, 2022 | T-141-22 | The Spirit Bear Coffee Company Inc. V. Kitasoo Band Council | S. 18.1 Application for Judicial Review | Vancouver | 1.3 d |
| Nov 3, 2022 | T-862-22 | Vision Travel Dt Ontario-west In V. Heather Calvert Et Al | Trade Mark - Passing Off | Toronto | 3 h |
| Nov 8, 2022 | T-954-22 | Ipack B.v. V. Mcinnes Cooper | Trade Mark - Appeal of a decision of the Registrar | Toronto | 2 h |
| Dec 8, 2022 | T-1172-21 | Standard International Management Llc V. Asia Standard Management Services L | Trade Mark - Appeal of a decision of the Registrar | Ottawa | 1 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location | Length |
| Sep 28, 2022 | A-57-21 | Maoz Betser-zilevitch V. Petrochina Canada Ltd | Appeal (S.27 - Final) - Others [from T-1158-18 - Patent Infringement] | Toronto | 5.5 h |
| Oct 5, 2022 | A-159-21 | Pharmascience Inc. V. Teva Canada Innovation Et Al - Glatiramer* | Appeal (S.27 - Final) - Others [from T-2182-18 - Patented Medicines (NOC) Regulations [Actions]] | Toronto | 2 h |
| Oct 6, 2022 | A-330-21 | Ims Incorporated Et Al V. The Toronto Regional Real Estate Board | Appeal (S.27 - Interloc.) - Copyright Act [from T-900-20 - Copyright Infringement [Actions]] | Toronto | 2 h |
| Oct 25, 2022 | A-250-21 | Google Llc V. The Privacy Commissioner Of Canada Et Al | Appeal (S.27 - Final) - Privacy [from T-1779-18 - S. 17(3) or 18.3 Reference] | Toronto | 1.3 d |
| Oct 27, 2022 | A-121-21 | Dtechs Epm Ltd V. British Columbia Hydro And Power Authority Et Al | Appeal (S.27 - Final) - Patent Act [from T-227-17 - Patent Infringement] | Calgary | 1 d |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.